Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV

Add this event to your calendar: iCal   Google Calendar


The Medicinal Chemistry Divisions of the two Belgian Chemical Societies, Société Royale de Chimie (SRC) and Koninklijke Vlaamse Chemische Vereniging (KVCV), are organising every year an international one-day symposium with the aim to update participants on selected areas of pharmaceutical research by specialists in their respective field.

MedChem 2018 will be held on Friday November 23, 2018, in Namur. The programme of the day will include six invited lectures and three oral communications selected from submitted abstracts.

This year, the symposium will delve around the latest developments in medicinal chemistry in the field of kinase inhibitors. With more than 35 small molecules approved by the FDA, mainly in oncology, kinase inhibition is still the subject of intense research efforts in both academia and industry. Several recent case studies in various therapeutic areas (transplant rejection, inflammation, oncology) will be presented by industrial speakers. Current challenges such as covalent inhibition, the importance of residence time, or the crucial issue of selectivity will also be addressed through presentations focusing on aspects of molecular biology or chemoinformatics.

In recent years, this symposium has been gathering around 150 participants at each edition, half from universities, half from industry, both from Belgium and surrounding countries. It has been focussing on topics such as:

  • The Many Pharmacotherapeutic Faces of Nucleosides and Oligonucleotides (2017)
  • PET & Imaging : From Chemistry Lab to Clinical Applications (2016)
  • New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era? (2014)
  • Constrained Peptides and Macrocycles – New Opportunities for Drug Discovery (2013)
  • From Rapid Dissociation to Irreversible Inhibition – Optimisation of Drug-Target Residence Time (2012)


Profile Early Fees Standard Fees Student - member 35 EUR 43 EUR Student - non member 55 EUR 65 EUR Academic - member 65 EUR 80 EUR Academic - non member 95 EUR 115 EUR Industry - member 95 EUR 115 EUR Industry - non member 175 EUR 210 EUR


Bernard Dacier

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.